Genomic Selection Platform Market (2026–2030): Industry Outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Genomic Selection Platform Market During The Forecast Period?

The genomic selection platform market has experienced significant expansion in recent years. It is anticipated to grow from $2.27 billion in 2025 to $2.66 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.1%. This historical growth can be linked to the proliferation of molecular breeding programs, enhanced availability of genotyping technologies, the adoption of statistical genomics models, an increasing need for more rapid breeding cycles, and rising research investments in genetics.

The genomic selection platform market size is anticipated to experience substantial growth in the coming years. It is projected to achieve a value of $4.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.8%. This expansion during the forecast period can be primarily attributed to the increasing adoption of genomic selection in agricultural practices, the rising application of predictive analytics in breeding programs, the wider development of sustainable crops and livestock, the growing integration of genomics with precision agriculture, and the advancement of cloud-native genomic platforms. Significant trends foreseen for the same period include the increasing incorporation of AI-driven genomic prediction models, the rising utilization of high-throughput genotyping platforms, the expanding integration of cloud-based breeding analytics, the enhancement of predictive breeding decision support systems, and a more pronounced focus on trait-based selection accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Genomic Selection Platform Market?

The expanding integration of personalized medicine is anticipated to fuel the expansion of the genomic selection platform market in the coming years. Personalized medicine represents a healthcare strategy focused on customizing treatment and prevention approaches to align with an individual’s distinct genetic composition, way of life, and surroundings. This rising embrace of personalized medicine is largely attributable to progress in genomics, which facilitates precise identification of genetic variations and the development of customized treatments for individuals. Genomic selection platforms play a crucial role in personalized medicine by delivering accurate genomic insights, making them perfectly suited for customizing patient treatments. These platforms minimize experimental approaches in therapy selection by forecasting responses to various interventions, thereby enhancing treatment efficacy and improving patient health outcomes. For example, in February 2024, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, a notable rise from the 12 approved in 2022, as reported by the US-based nonprofit organization, the Personalized Medicine Coalition (PMC). Consequently, the growing acceptance of personalized medicine is a key driver for the genomic selection platform market.

How Is Segmentation Applied In The Genomic Selection Platform Market Segment Analysis?

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

Which Trends Are Shaping The Genomic Selection Platform Market?

Entities within the genomic selection platform market are prioritizing the development of innovative offerings, such as targeted sequencing platforms, to enhance trait prediction and accelerate breeding programs. Targeted sequencing platforms refer to genomic technologies designed to sequence specific regions of the genome rather than the entire genome. For example, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, an advanced targeted sequencing platform that simplifies exome capture by integrating traditionally complex steps into its AVITI System. This platform removes the need for specialized equipment, reduces manual processing time by up to five hours, and offers a one-hour hybridization option for same-day results, making it well-suited for time-sensitive research. Trinity also supports custom panels for applications such as oncology, respiratory diseases, and minimal residual disease (MRD), delivering faster, more cost-efficient, and accessible sequencing while marking a significant advancement in exome capture technology.

Who Are The Companies Participating In The Genomic Selection Platform Market Environment?

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Get The Full Genomic Selection Platform Market Report:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Which Region Has The Greatest Market Share In The Genomic Selection Platform Market?

North America was the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Genomic Selection Platform Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Browse Through More Reports Similar to the Global Genomic Selection Platform Market 2026, By The Business Research Company

Bioinformatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795